Fibrous Dysplasia Market Accretes a Voluminous Growth by 2023 with a Whooping Double Digit CAGR of ~6.2%; Asserts MRFR
Market Research Future
The Global Fibrous Dysplasia Market report titled “Fibrous Dysplasia Market Research Report-Forecast to 2023″ is a specialist investigation report by Market Research Future includes broad essential research alongside the definite examination of subjective and additionally quantitative perspectives by different industry specialists, key sentiment pioneers to pick up a more profound understanding of the market and industry execution. Considering all these factors The World Fibrous Dysplasia Market research report is
Market Research Future published new report, titled “Fibrous Dysplasia Market -Research Report: Global Forecast till 2023”.
The Worldwide Fibrous Dysplasia Market report explores the Top Key Players in-depth analysis as; Novartis AG, Pfizer Inc, Amgen Inc, AVEO Pharmaceuticals Inc, Bayer AG, Bellicum Pharmaceuticals Inc, MediaPharma srl, Merck & Co., Inc, Merrimack Pharmaceuticals Inc, Oncolys BioPharma Inc, United Therapeutics Corp and others.
Fibrous dysplasia market is a rare and chronic bone disorder in which fibrous tissue develops in place of normal bone, weakens the affected bone, and deform or fracture it. As per reports from The Johns Hopkins University, the exact cause of fibrous dysplasia is unknown, but it is believed to be due to a chemical irregularity in a specific bone protein. This bone protein abnormality may arise due to a gene mutation present at birth, although it is not known to be an inherited disorder.
It often results in uneven growth of bones, pain, brittle bones, and bone deformity. In fibrous dysplasia, the most commonly affected bones includes femur (thighbone), tibia (shin bone), ribs, skull, facial bones, humerus (the bone of the upper arm), pelvis, vertebrae in the spine (less often).
The fibrous dysplasia market growth is majorly attributed to the increasing prevalence of the bone disorders. Moreover, some cases of fibrous dysplasia leads to cancer, which is likely to drive the market growth.
Currently, no cure is available for fibrous dysplasia. However, present treatment methods helps to prevent complications, such as recurrent bone fractures to help make the condition less severe.
According to reports from International Osteoporosis Foundation, Each year an estimated 1.5 million individuals suffer a fracture due to bone disease. The risk of a fracture increases with age and is more in women. Furthermore, globalization in healthcare has increased the market growth. Established market players in the developed countries leads the globalization by pushing new products and services into developing countries and emerging economies.
However, high cost of the current treatment methods and lack of alternative methods for the treatment of fibrous dysplasia may slow the market growth during the forecast period.
The global fibrous dysplasia market is segmented on the basis by diagnosis, by treatment, and by end user.
On the basis of diagnosis, it is segmented into X-rays, CT scans, MRI, bone scan, biopsy, and others.
On the basis of treatment, it is segmented into medications, surgical, and others. The medications is further segmented into bisphosphonates, intravenous (IV) pamidronate, calcitonin, raloxifene, and others
On the basis of the end user, it is segmented into hospitals & clinics, research centers, and others.
The Americas dominate the global fibrous dysplasia market owing to well-developed technology, increasing patient with bone disorders, high healthcare spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.
Europe holds the second position in the global fibrous dysplasia market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period.
Asia Pacific is the fastest growing market owing to the presence of rapidly developing healthcare technology, increasing patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods in countries such as India is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is projected to lead to the use of advanced equipment, which, in turn, may increase the market growth of the fibrous dysplasia in the region.
On the other hand, the Middle East & Africa holds the least share of the global fibrous dysplasia market due to limited screening, ignorance of diseases, and poor access to treatment, especially, in African region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.
Table Of Content: 1 Report Prologue 2 Market Introduction 2.1 Definition 2.2 Scope Of The Study 2.2.1 Research Objective 2.2.2 Assumptions 2.2.3 Limitations 3 Research Methodology 3.1 Introduction 3.2 Primary Research 3.3 Secondary Research 3.4 Market Size Estimation 4 Market Dynamics 4.1 Drivers 4.2 Restrains 4.3 Opportunities 4.4 Challenges 4.5 Macroeconomic Indicators 4.6 Technology Trends & Assessment 5 Market Factor Analysis 5.1 Porters Five Forces Analysis 5.1.1 Bargaining Power Of Suppliers 5.1.2 Bargaining Power Of Buyers 5.1.3 Threat Of New Entrants 5.1.4 Threat Of Substitutes 5.1.5 Intensity Of Rivalry 5.2 Value Chain Analysis 5.3 Investment Feasibility Analysis 5.4 Pricing Analysis
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions